Skip to main content
. 2018 Aug 23;2018:8490242. doi: 10.1155/2018/8490242

Figure 2.

Figure 2

The prevalence of nonalcoholic fatty liver disease (NAFLD) as detected by ultrasound in relationship to the number of components of metabolic syndrome (final cohort, N=159 patients). There is a statistically significant trend of increase in proportion of NAFLD among patients with rising number of metabolic syndrome components, the Χ2 test for trend, P<0.001.